Medterials is a privately held corporation based in the San Francisco Bay Area. With over a century of combined experience in medical device, biomaterial, biochemistry, and polymer chemistry, they specialize in the development of combination medical products that merge medical devices and drugs. Their comprehensive range of products and services includes the design and development of drug administration devices, drug-containing coatings, and biodegradable microspheres for drug encapsulation.

Medterials also offers small-scale GMP manufacturing, ensuring a seamless transition from product development to clinical development. They have a particular expertise in medical products for ophthalmology and interventional medicine. The entire staff at Medterials is highly skilled and possesses a technical background, enabling them to be hands-on throughout the development process.

The company boasts an impressive track record of more than 50 granted patents for medical devices, polymeric drug formulations, and combination products, along with successfully developing over 30 products. Medterials collaborates with established partners for medical device molding and fabrication, research animal model development, and large-scale GMP manufacturing. With a team of experienced professionals, including founders Stan Conston and Ron Yamamoto, Medterials is committed to providing top-quality solutions for the medical industry